About Hagai
Healthcare strategy and market access leader with 15+ years of experience across government and industry, including leading national health system planning (~$12B budget) and driving commercialization of diagnostic innovations.
I work with healthtech and diagnostics companies to bridge the gap between innovation and adoption by developing market access strategies, reimbursement pathways, and health economics-driven value propositions, alongside building strategic partnerships with payers, providers, health systems, and industry partners.
Recent work includes building the business case and go-to-market strategy for a novel oral cancer diagnostic, leading market access strategy for cervical cancer screening solutions, and advising on system-level adoption of diagnostic technologies.
I bring a unique combination of policy, economics, and real-world implementation, helping companies move from product to reimbursed, scalable solutions.
Hebrew
Native or bilingual
English
Native or bilingual
Can work on-site
Cary (up to 50km)
Experience
- Independent ConsultantHealthcare Strategy & Market AccessOctober 2025 - April 2026 (6 months)
- Advised a geriatric hospital on economic optimization and government-payer strategy, improving revenue capture, operational efficiency, and alignment with public reimbursement frameworks
- Supported a healthtech startup in U.S. go-to-market strategy for solutions addressing anti-microbial resistance (AMR) in hospital settings, including positioning, stakeholder mapping, and adoption pathways
- Provided consulting services to a multinational medical device company, leading market access strategy and government relations to shape payer engagement and policy positioning for product adoption
- Provide ongoing advisory to healthtech and diagnostics companies on reimbursement, health economics, and strategic partnerships, including value proposition development and market entry planning
- Becton Dickinson (BD)Market Access & Commercial Development ManagerFebruary 2025 - October 2025 (8 months)• • Led portfolio growth, market access, and market entry initiatives for innovative diagnostics and technologies, working with health systems, government stakeholders, and professional societies to support adoption at scale.• • Built business plans and market entry cases for new products, translating clinical value, economic trade-offs, reimbursement considerations, and system constraints into structured growth recommendations for corporate decision-making.• • Partnered closely with regional and global corporate teams in Europe and the United States across strategy, market access, and commercial functions to align local execution with global priorities.• • Built and led cross-functional initiatives with medical, regulatory, and commercial teams to introduce global products into the local market through partnerships with KOLs and leading providers.• • Served as a senior interface with public health authorities and payers, contributing to policy discussions, servicedelivery models, and financing approaches that support long-term technology adoption.• • Identified and evaluated new growth opportunities by aligning unmet clinical needs with BD's portfolio, informing prioritization and partnership decisions.
- SalignosticsHead of Strategy & Business DevelopmentJuly 2023 - January 2025 (1 year and 6 months)• • Owned company-level growth and partnership strategy for saliva-based diagnostic technologies spanning women's health, oncology, and decentralized testing markets.• • Led licensing, co-development, and strategic partnership discussions with multinational healthcare companies, including the signing of a licensing and partnership agreement with a market-leading global corporation.• • Oversaw strategic collaborations with leading hospitals and research institutions, including the establishment of a co-development partnership with a top-tier cancer center.• • Defined value propositions and market expansion priorities through competitive analysis and market assessment, guiding portfolio decisions and supporting commercialization and scale.• • Coordinated investor engagement and capital-raising efforts, including mapping and approaching potential investors, developing investor decks and business plans, and presenting the company's strategy and growth roadmap to investors.• • Reported directly to the Board of Directors, supporting strategic decision-making during key inflection points in the company's growth.
Recommendations
Be the first to recommend Hagai
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- Master of Public PolicyHebrew University of Jerusalem2009Master of Public Policy
- Bachelor of Arts, EconomicsHebrew University of Jerusalem2003Bachelor of Arts (BA)